Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous oxide plus lidocaine for comfort in outpatient plastic surgery
ChiCTR2400080612Phase 4Not yet recruiting
- Sponsor
- Qingdao Municipal Hospital
- Start
- Feb 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of nitrous oxide, lidocaine, epinephrine and oxygen in anxiety disorder (2 arms), sponsored by Qingdao Municipal Hospital. Primary endpoints: Pain, Blood pressure and 1 more. Planned start Feb 2024; status: not yet recruiting.
02
Drugs
nitrous oxidelidocaineepinephrineoxygen
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on ChiCTR2400080612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080612.